| Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction D Westermann, D Lindner, M Kasner, C Zietsch, K Savvatis, F Escher, ... Circulation: Heart Failure 4 (1), 44-52, 2011 | 784 | 2011 |
| Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies K Wahbi, R Ben Yaou, E Gandjbakhch, F Anselme, T Gossios, ... Circulation 140 (4), 293-302, 2019 | 287 | 2019 |
| Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment J Yang, K Savvatis, JS Kang, P Fan, H Zhong, K Schwartz, V Barry, ... Nature communications 7 (1), 13710, 2016 | 277 | 2016 |
| Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial G Giamouzis, J Butler, RC Starling, G Karayannis, J Nastas, C Parisis, ... Journal of cardiac failure 16 (12), 922-930, 2010 | 245 | 2010 |
| Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study JB Augusto, R Eiros, E Nakou, S Moura-Ferreira, TA Treibel, G Captur, ... European Heart Journal-Cardiovascular Imaging 21 (3), 326-336, 2020 | 226 | 2020 |
| Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy D Westermann, T Walther, K Savvatis, F Escher, M Sobirey, A Riad, ... Diabetes 58 (6), 1373-1381, 2009 | 138 | 2009 |
| Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure D Westermann, A Riad, O Lettau, A Roks, K Savvatis, PM Becher, ... Hypertension 52 (6), 1068-1075, 2008 | 118 | 2008 |
| Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy A Rahnefeld, K Klingel, A Schuermann, NL Diny, N Althof, A Lindner, ... Circulation 130 (18), 1589-1600, 2014 | 117 | 2014 |
| Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy D Westermann, K Savvatis, D Lindner, C Zietsch, PM Becher, E Hammer, ... Circulation 124 (19), 2082-2093, 2011 | 115 | 2011 |
| Role of Heart Rate Reduction in the Prevention of Experimental Heart Failure: Comparison Between If-Channel Blockade and β-Receptor Blockade PM Becher, D Lindner, K Miteva, K Savvatis, C Zietsch, B Schmack, ... Hypertension 59 (5), 949-957, 2012 | 114 | 2012 |
| Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator A Protonotarios, R Bariani, C Cappelletto, M Pavlou, A García-García, ... European heart journal 43 (32), 3053-3067, 2022 | 111 | 2022 |
| Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis K Savvatis, I Müller, M Fröhlich, K Pappritz, C Zietsch, N Hamdani, K Grote, ... Basic research in cardiology 109 (6), 449, 2014 | 109 | 2014 |
| Adult granulosa cell tumors of the ovary: tumor dissemination pattern at primary and recurrent situation, surgical outcome C Fotopoulou, K Savvatis, EI Braicu, V Brink-Spalink, S Darb-Esfahani, ... Gynecologic oncology 119 (2), 285-290, 2010 | 108 | 2010 |
| Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo D Westermann, PM Becher, D Lindner, K Savvatis, Y Xia, M Fröhlich, ... Basic research in cardiology 107 (6), 308, 2012 | 104 | 2012 |
| Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor S Pinkert, D Westermann, X Wang, K Klingel, A Dörner, K Savvatis, ... Circulation 120 (23), 2358-2366, 2009 | 101 | 2009 |
| TRIF is a critical survival factor in viral cardiomyopathy A Riad, D Westermann, C Zietsch, K Savvatis, PM Becher, S Bereswill, ... The Journal of Immunology 186 (4), 2561-2570, 2011 | 99 | 2011 |
| Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure D Westermann, A Riad, U Richter, S Jäger, K Savvatis, M Schuchardt, ... Basic Research in Cardiology 104 (5), 499-509, 2009 | 96 | 2009 |
| Maximal-effort cytoreductive surgery for ovarian cancer patients with a high tumor burden: variations in practice and impact on outcome M Hall, K Savvatis, K Nixon, M Kyrgiou, K Hariharan, M Padwick, ... Annals of surgical oncology 26 (9), 2943, 2019 | 94 | 2019 |
| NOD2 (nucleotide-binding oligomerization domain 2) is a major pathogenic mediator of coxsackievirus B3-induced myocarditis C Tschöpe, I Müller, Y Xia, K Savvatis, K Pappritz, S Pinkert, D Lassner, ... Circulation: Heart Failure 10 (9), e003870, 2017 | 93 | 2017 |
| Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3–induced myocarditis A Weithauser, P Bobbert, S Antoniak, A Böhm, BH Rauch, K Klingel, ... Journal of the American College of Cardiology 62 (19), 1737-1745, 2013 | 93 | 2013 |
Tschope cGerman Heart Center at Charité (DHZC) and Institute of Health (BIH/ BCRT ) at Charite , BerlinVerified email at dhzc-charite.de
